As with the other talks in this session, this will present a brief overview of my career path at the interface of computers and chemistry with the idea of seeding the conversation during the panel discussion. This covers a move from an academic career path to a startup environment to large pharma and, possibly, back to a startup as well as a transition from doing computational solid-state chemistry to machine learning to computer-aided drug discovery to research IT.

From academia, to startup, to big pharma, and back again?

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.